Euroopa Liit - eesti - EMA (European Medicines Agency)

accord healthcare s.l.u. - temosolomiid - glioma; glioblastoma - antineoplastilised ained - uute diagnoositud multiformse glioblastoomi täiskasvanud patsientide raviks koos kiiritusravi (rt) ja seejärel monoteraapiaga. ravi lapsed vanuses kolm aastat, noorukid ja täiskasvanud patsientidele, kellel on pahaloomuline glioma, nagu glioblastoma erüteem või anaplastic astrocytoma, näidates kordumise või progresseerumise pärast standardset ravi.

Eesti - eesti - Ravimiamet

viatris healthcare limited - laktuloos - suukaudne lahus - 667mg 1ml 300ml 1tk; 667mg 1ml 15ml 20tk; 667mg 1ml 500ml 1tk; 667mg 1ml 800ml 1tk; 667mg 1ml 200ml 1tk; 667mg 1ml 1000ml 1tk

Eesti - eesti - Ravimiamet

norbrook laboratories (ireland) limited - fiproniil+metopreen - täpilahus - 134mg+120,6mg 1.34ml 1.34ml 8tk; 134mg+120,6mg 1.34ml 1.34ml 2tk; 134mg+120,6mg 1.34ml 1.34ml 30tk; 134mg+120,6mg 1.34ml 1.34ml 4tk; 134mg+120,6mg 1.34ml 1.34ml 12tk; 134mg+120,6mg 1.34ml 1.34ml 60tk; 134mg+120,6mg 1.34ml 1.34ml 3tk; 134mg+120,6mg 1.34ml 1.34ml 120tk; 134mg+120,6mg 1.34ml 1.34ml 150tk; 134mg+120,6mg 1.34ml 1.34ml 90tk; 134mg+120,6mg 1.34ml 1.34ml 24tk

Eesti - eesti - Ravimiamet

b. braun melsungen ag - kombinatsioonid - infusiooniemulsioon - 1875ml 5tk; 1250ml 5tk

Eesti - eesti - Ravimiamet

b. braun melsungen ag - kombinatsioonid - infusiooniemulsioon - 625ml 5tk; 1875ml 5tk; 1250ml 5tk

Eesti - eesti - Ravimiamet

norbrook laboratories (ireland) limited - fiproniil+metopreen - täpilahus - 268mg+241,2mg 2.68ml 2.68ml 30tk; 268mg+241,2mg 2.68ml 2.68ml 24tk; 268mg+241,2mg 2.68ml 2.68ml 8tk; 268mg+241,2mg 2.68ml 2.68ml 90tk; 268mg+241,2mg 2.68ml 2.68ml 2tk; 268mg+241,2mg 2.68ml 2.68ml 3tk; 268mg+241,2mg 2.68ml 2.68ml 12tk; 268mg+241,2mg 2.68ml 2.68ml 6tk; 268mg+241,2mg 2.68ml 2.68ml 150tk; 268mg+241,2mg 2.68ml 2.68ml 4tk; 268mg+241,2mg 2.68ml 2.68ml 120tk; 268mg+241,2mg 2.68ml 2.68ml 1tk

Eesti - eesti - Ravimiamet

norbrook laboratories (ireland) limited - fiproniil+metopreen - täpilahus - 50mg+60mg 0.5ml 0.5ml 2tk; 50mg+60mg 0.5ml 0.5ml 24tk; 50mg+60mg 0.5ml 0.5ml 8tk; 50mg+60mg 0.5ml 0.5ml 3tk; 50mg+60mg 0.5ml 0.5ml 4tk; 50mg+60mg 0.5ml 0.5ml 12tk

Eesti - eesti - Ravimiamet

norbrook laboratories (ireland) limited - fiproniil+metopreen - täpilahus - 67mg+60,3mg 0.67ml 0.67ml 8tk; 67mg+60,3mg 0.67ml 0.67ml 6tk; 67mg+60,3mg 0.67ml 0.67ml 12tk; 67mg+60,3mg 0.67ml 0.67ml 1tk; 67mg+60,3mg 0.67ml 0.67ml 4tk; 67mg+60,3mg 0.67ml 0.67ml 24tk; 67mg+60,3mg 0.67ml 0.67ml 3tk; 67mg+60,3mg 0.67ml 0.67ml 2tk

Eesti - eesti - Ravimiamet

norbrook laboratories (ireland) limited - fiproniil+metopreen - täpilahus - 402mg+361,8mg 4.02ml 4.02ml 120tk; 402mg+361,8mg 4.02ml 4.02ml 8tk; 402mg+361,8mg 4.02ml 4.02ml 12tk; 402mg+361,8mg 4.02ml 4.02ml 4tk; 402mg+361,8mg 4.02ml 4.02ml 24tk; 402mg+361,8mg 4.02ml 4.02ml 30tk; 402mg+361,8mg 4.02ml 4.02ml 90tk; 402mg+361,8mg 4.02ml 4.02ml 6tk; 402mg+361,8mg 4.02ml 4.02ml 1tk; 402mg+361,8mg 4.02ml 4.02ml 60tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

aimmune therapeutics ireland limited - defatted powder of arachis hypogaea l., semen (peanuts) - peanut hypersensitivity - allergens - palforzia is indicated for the treatment of patients aged 4 to 17 years with a confirmed diagnosis of peanut allergy. palforzia may be continued in patients 18 years of age and older. palforzia should be used in conjunction with a peanut-avoidant diet.